CTR EXAM PRACTICE TEST
QUESTIONS WITH VERIFIED ANSWERS LATEST UPDATE
Question 1.
The cancer conference coordinator monitors and evaluates the cancer conference activities and
reports to the cancer committee at least
ANSWER
Each calendar year
Question 2.
A formal procedure to check data accuracy against source documents is called:
ANSWER
Reabstracting study
Question 3.
The class of case data item describes all of the following, EXCEPT ...
a. Whether or not a case is reportable to the Commission on Cancer.
b. Whether a case was malignant or benign.
c. Whether the reporting facility diagnosed or treated the patient.
d. Whether the case needs to be followed
ANSWER
b. Whether a case was malignant or benign.
Question 4.
The date of diagnosis for a patient diagnosed in utero:
ANSWER
Is the actual date of diagnosis
Question 5.
What are the two main types of central cancer registries?
ANSWER
Population based and multi hospital or non population based.
, Question 6.
The timing of SEER Extent of Disease coding is limited to:
ANSWER
All information available through completion of surgeries in the first course of treatment or
four months, whichever is longer.
Question 7.
According to the Commission on Cancer of the American College of Surgeons, the target percentage
rate for follow-up of all eligible analytic cases is:
ANSWER
80%
Question 8.
The diagnosis is "undifferentiated NK-cell leukemia." What is the grade/differentiation?
ANSWER
8
Reference: pg 22 of ICD-O-3
Question 9.
A cystadenocarcinoma would most likely arise in which of the following organs?
ANSWER
Ovary
Question 10.
The three leading cancer sites among white American males are:
ANSWER
Prostate, colorectal, and lung
QUESTIONS WITH VERIFIED ANSWERS LATEST UPDATE
Question 1.
The cancer conference coordinator monitors and evaluates the cancer conference activities and
reports to the cancer committee at least
ANSWER
Each calendar year
Question 2.
A formal procedure to check data accuracy against source documents is called:
ANSWER
Reabstracting study
Question 3.
The class of case data item describes all of the following, EXCEPT ...
a. Whether or not a case is reportable to the Commission on Cancer.
b. Whether a case was malignant or benign.
c. Whether the reporting facility diagnosed or treated the patient.
d. Whether the case needs to be followed
ANSWER
b. Whether a case was malignant or benign.
Question 4.
The date of diagnosis for a patient diagnosed in utero:
ANSWER
Is the actual date of diagnosis
Question 5.
What are the two main types of central cancer registries?
ANSWER
Population based and multi hospital or non population based.
, Question 6.
The timing of SEER Extent of Disease coding is limited to:
ANSWER
All information available through completion of surgeries in the first course of treatment or
four months, whichever is longer.
Question 7.
According to the Commission on Cancer of the American College of Surgeons, the target percentage
rate for follow-up of all eligible analytic cases is:
ANSWER
80%
Question 8.
The diagnosis is "undifferentiated NK-cell leukemia." What is the grade/differentiation?
ANSWER
8
Reference: pg 22 of ICD-O-3
Question 9.
A cystadenocarcinoma would most likely arise in which of the following organs?
ANSWER
Ovary
Question 10.
The three leading cancer sites among white American males are:
ANSWER
Prostate, colorectal, and lung